| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
|
N Engl J Med
|
2011
|
10.79
|
|
2
|
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
|
N Engl J Med
|
2012
|
6.64
|
|
3
|
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
|
Lancet
|
2009
|
4.84
|
|
4
|
Placental malaria increases malaria risk in the first 30 months of life.
|
Clin Infect Dis
|
2008
|
2.69
|
|
5
|
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon.
|
J Infect Dis
|
2005
|
2.58
|
|
6
|
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
|
Lancet Infect Dis
|
2011
|
2.54
|
|
7
|
Fosmidomycin for malaria.
|
Lancet
|
2002
|
2.03
|
|
8
|
High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults.
|
Am J Trop Med Hyg
|
2007
|
1.99
|
|
9
|
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
|
J Infect Dis
|
2007
|
1.99
|
|
10
|
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon.
|
J Infect Dis
|
2008
|
1.70
|
|
11
|
Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study).
|
BMC Infect Dis
|
2010
|
1.57
|
|
12
|
History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon.
|
Wien Klin Wochenschr
|
2007
|
1.52
|
|
13
|
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.
|
J Infect Dis
|
2008
|
1.51
|
|
14
|
Socio-economic status is inversely related to bed net use in Gabon.
|
Malar J
|
2008
|
1.46
|
|
15
|
Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children.
|
Malar J
|
2007
|
1.23
|
|
16
|
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.
|
J Infect Dis
|
2010
|
1.21
|
|
17
|
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
|
Clin Infect Dis
|
2005
|
1.18
|
|
18
|
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon.
|
Antimicrob Agents Chemother
|
2003
|
1.18
|
|
19
|
Clinical and parasitological characteristics of puerperal malaria.
|
J Infect Dis
|
2005
|
1.15
|
|
20
|
Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severity.
|
Malar J
|
2008
|
1.12
|
|
21
|
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.
|
Antimicrob Agents Chemother
|
2007
|
1.12
|
|
22
|
Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon.
|
Malar J
|
2008
|
1.10
|
|
23
|
New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria.
|
Am J Trop Med Hyg
|
2002
|
1.10
|
|
24
|
The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial.
|
PLoS One
|
2013
|
1.09
|
|
25
|
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.
|
BMC Med
|
2014
|
1.07
|
|
26
|
Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D).
|
PLoS One
|
2011
|
1.04
|
|
27
|
No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon.
|
J Infect Dis
|
2009
|
1.01
|
|
28
|
Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa.
|
Acta Trop
|
2012
|
1.01
|
|
29
|
Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambaréné, Gabon.
|
Vaccine
|
2009
|
1.00
|
|
30
|
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
|
31
|
DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria.
|
J Infect Dis
|
2004
|
0.97
|
|
32
|
A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon.
|
Malar J
|
2011
|
0.97
|
|
33
|
Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children.
|
Clin Infect Dis
|
2003
|
0.97
|
|
34
|
Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks.
|
Infect Immun
|
2004
|
0.97
|
|
35
|
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children.
|
Malar J
|
2011
|
0.96
|
|
36
|
Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children.
|
J Infect Dis
|
2005
|
0.96
|
|
37
|
Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single- versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection.
|
Antimicrob Agents Chemother
|
2014
|
0.96
|
|
38
|
A longitudinal study of allergy and intestinal helminth infections in semi urban and rural areas of Flores, Indonesia (ImmunoSPIN Study).
|
BMC Infect Dis
|
2011
|
0.96
|
|
39
|
Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.
|
Clin Infect Dis
|
2002
|
0.94
|
|
40
|
Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections.
|
J Antimicrob Chemother
|
2002
|
0.93
|
|
41
|
Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria.
|
Hum Immunol
|
2010
|
0.92
|
|
42
|
Buruli ulcer in Gabon, 2001-2010.
|
Emerg Infect Dis
|
2012
|
0.92
|
|
43
|
WHO 2006 child growth standards: implications for the prevalence of stunting and underweight-for-age in a birth cohort of Gabonese children in comparison to the Centers for Disease Control and Prevention 2000 growth charts and the National Center for Health Statistics 1978 growth references.
|
Public Health Nutr
|
2008
|
0.92
|
|
44
|
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria.
|
Malar J
|
2008
|
0.91
|
|
45
|
Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection.
|
Malar J
|
2011
|
0.91
|
|
46
|
Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children.
|
Clin Infect Dis
|
2003
|
0.90
|
|
47
|
Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes.
|
BMC Genet
|
2010
|
0.89
|
|
48
|
Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis?
|
J Infect Dis
|
2009
|
0.86
|
|
49
|
Clinical, environmental, and serologic surveillance studies of melioidosis in Gabon, 2012-2013.
|
Emerg Infect Dis
|
2015
|
0.85
|
|
50
|
Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.
|
Antimicrob Agents Chemother
|
2002
|
0.84
|
|
51
|
Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection.
|
Malar J
|
2009
|
0.83
|
|
52
|
Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.
|
Antimicrob Agents Chemother
|
2012
|
0.83
|
|
53
|
Limit of blank and limit of detection of Plasmodium falciparum thick blood smear microscopy in a routine setting in Central Africa.
|
Malar J
|
2014
|
0.83
|
|
54
|
NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity.
|
Malar J
|
2008
|
0.81
|
|
55
|
Haematological and biochemical reference intervals for infants and children in Gabon.
|
Trop Med Int Health
|
2010
|
0.81
|
|
56
|
Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups.
|
Malar J
|
2013
|
0.80
|
|
57
|
Developing information technology at the Medical Research Unit of the Albert Schweitzer Hospital in Lambaréné, Gabon.
|
Wien Klin Wochenschr
|
2010
|
0.79
|
|
58
|
Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial.
|
Malar J
|
2008
|
0.78
|
|
59
|
The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel.
|
Malar J
|
2011
|
0.78
|
|
60
|
Medical research at the Albert Schweitzer Hospital.
|
Wien Klin Wochenschr
|
2010
|
0.77
|
|
61
|
Cost-effectiveness of intermittent preventive treatment of malaria in infants (IPTi) for averting anaemia in Gabon: a comparison between intention to treat and according to protocol analyses.
|
Malar J
|
2011
|
0.77
|
|
62
|
Assessment of LED fluorescence microscopy for the diagnosis of Plasmodium falciparum infections in Gabon.
|
Malar J
|
2011
|
0.75
|
|
63
|
A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasis.
|
Genet Test Mol Biomarkers
|
2012
|
0.75
|
|
64
|
In-vitro characterization of novel and functional regulatory SNPs in the promoter region of IL2 and IL2R alpha in a Gabonese population.
|
BMC Med Genet
|
2012
|
0.75
|
|
65
|
Malaria and money.
|
Wien Klin Wochenschr
|
2004
|
0.75
|